Literature DB >> 7794205

High prevalence of thyroid function test abnormalities in chronic schizophrenia.

S S Othman1, K Abdul Kadir, J Hassan, G K Hong, B B Singh, N Raman.   

Abstract

The thyroid status of 249 patients with chronic schizophrenia (males = 136, females = 113) with a median age of 36 years (range: 16 to 58 years) and a median duration of hospitalisation of 10 years (range: 1 to 30 years) was assessed. Thyroid antibodies (TAb) were found in 51 patients (20%). In female patients, 32 (28%) were TAb positive compared to 13% (n = 152, p = 0.01) in healthy female blood donors. In male patients, the prevalence of TAb was 14% compared to 7% (n = 449, p = 0.01) in healthy male blood donors. Of the 183 patients who had thyroid hormone measurements, 60% had normal test, 5% had elevated TSH and 17% had low TSH. The T4, FT41 and FT31 were significantly lower in those with low or high TSH (p < 0.001) compared to those with normal TSH. Of the 143 patients with normal TSH, 33 (23%) had low T3. In conclusion, there is a spectrum of thyroid function test abnormalities in chronic schizophrenia; this may be related to an abnormality in the central regulation of the hypothalamo-pituitary thyroid axis as well as at the peripheral level. However the association between chronic schizophrenia and the presence of thyroid antibodies, and the clinical relevance of these biochemical abnormalities, are still not clear.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7794205     DOI: 10.3109/00048679409080785

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  9 in total

Review 1.  Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.

Authors:  Meritxell Tost; José Antonio Monreal; Antonio Armario; Juan David Barbero; Jesús Cobo; Clemente García-Rizo; Miquel Bioque; Judith Usall; Elena Huerta-Ramos; Virginia Soria; Javier Labad
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859

2.  Factors affecting hospital stay in psychiatric patients: the role of active comorbidity.

Authors:  Athanassios Douzenis; Dionysios Seretis; Stella Nika; Paraskevi Nikolaidou; Athanassia Papadopoulou; Emmanouil N Rizos; Christos Christodoulou; Christos Tsopelas; Dominic Mitchell; Lefteris Lykouras
Journal:  BMC Health Serv Res       Date:  2012-06-19       Impact factor: 2.655

3.  Revisiting thyroid hormones in schizophrenia.

Authors:  Nadine Correia Santos; Patrício Costa; Dina Ruano; António Macedo; Maria João Soares; José Valente; Ana Telma Pereira; Maria Helena Azevedo; Joana Almeida Palha
Journal:  J Thyroid Res       Date:  2012-03-26

4.  Levothyroxine Augmentation in Clozapine Resistant Schizophrenia: A Case Report and Review.

Authors:  Ruohollah Seddigh; Somayeh Azarnik; Amir-Abbas Keshavarz-Akhlaghi
Journal:  Case Rep Psychiatry       Date:  2015-05-11

5.  HLA DRB1*03 as a possible common etiology of schizophrenia, Graves' disease, and type 2 diabetes.

Authors:  Aicha Sayeh; Cheker Ben Cheikh; Ali Mardessi; Meriem Mrad; Brahim Nsiri; Abdelaziz Oumaya; Najiba Fekih-Mrissa
Journal:  Ann Gen Psychiatry       Date:  2017-02-02       Impact factor: 3.455

6.  Successful Management of Patient with Sheehan's Syndrome Presenting with Psychosis and Catatonia.

Authors:  Santanu Nath; Rajeev Ranjan; Debadatta Mohapatra; Biswa Ranjan Mishra
Journal:  Indian J Psychol Med       Date:  2018 May-Jun

7.  Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis.

Authors:  Alexis E Cullen; Scarlett Holmes; Thomas A Pollak; Graham Blackman; Dan W Joyce; Matthew J Kempton; Robin M Murray; Philip McGuire; Valeria Mondelli
Journal:  Biol Psychiatry       Date:  2018-06-28       Impact factor: 13.382

8.  Schizophrenia: from epidemiology to rehabilitation.

Authors:  Gioia Mura; Donatella Rita Petretto; Krishna M Bhat; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-07-10

9.  Free Thyroxine Concentrations Moderate the Response to a Cognitive Remediation Therapy in People With Early Psychosis: A Pilot Randomized Clinical Trial.

Authors:  Francesc Estrada; Josep Maria Crosas; Maribel Ahuir; Sara Pérez-Muñoz; Wanda Zabala; Raquel Aguayo; Juan David Barbero; Itziar Montalvo; Meritxell Tost; Laura Llauradó; Armand Guardia; Diego Palao; José Antonio Monreal; Javier Labad
Journal:  Front Psychiatry       Date:  2020-07-07       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.